We Did It! MetaOptima Announced As A Ready To Rocket Winner
Every year, Ready To Rocket announces an exclusive list of BC tech companies set to make a measurable impact within the community. Today, MetaOptima was announced as a Ready To Rocket company in the Digital Health sector for its development of DermEngine, our intelligent dermatology software!
Integration: Making Your EMR Work For You
EMR software is the core of a dermatologist’s practice; it documents patient visits, stores data, and centralizes information for future reference. Why is it so hard to find a system that keeps up with current needs, and how is integration proving to be a solution to this very real problem?
Powering AI To Create A Patient-Centric Ecosystem
Artificial intelligence has been commonly used in the business world for its basic automation. Applied to pathology and dermatology, AI’s power can analyze patient images as a clinical decision support tool while connecting medical workers to create an optimized patient healthcare ecosystem.
MetaOptima honoured to host the official BC Supercluster announcement
MetaOptima is honoured to be the host of the first official Digital Tech Supercluster announcement. With a total investment of 950 millions by the Federal Government, Round 1 of this project is expected to drive Canada’s digital future with a $5B GDP boost and +13,000 jobs created in 10 years.
MetaOptima Presenting at AAD 2019
MetaOptima’s team is on the ground at AAD 2019 in Washington DC! Visit booth 4320 for a chance to see our latest products and features and share on the excitement of how technology is revolutionizing dermatology.
MetaOptima benefits from free-trade with CPTPP partners
As Canada ratifies its active role in the PCTPP agreement, Canadian business benefit from strategic free-trade exchange with members. MetaOptima directly enjoys tax-free operation for its Australia-based business activity expected to boost the ongoing expansion of the company in the region.
Success Or Failure: Where Is Teledermatology Set To Stand? - Part 2
Some nations’ implementation strategies have proven to be drivers in overcoming technical and regulatory obstacles when applying teledermatology in their health system. The U.S. and other nations should attempt to imitate and build upon these methods to facilitate further global adoption.